Kinase inhibitors in the treatment of chronic hepatitis C virus.
E
E
Bardou-Jacquet
R
R
Lorho
D
D
Guyader
D000328:Adult; D000998:Antiviral Agents / Q000627:therapeutic use*; D000069347:Erlotinib Hydrochloride; D017809:Fatal Outcome; D005500:Follow-Up Studies; D019698:Hepatitis C, Chronic / Q000188:drug therapy*; D006801:Humans; D016031:Liver Transplantation; D008297:Male; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use*; D011799:Quinazolines / Q000627:therapeutic use*
D000998:Antiviral Agents; D047428:Protein Kinase Inhibitors; D011799:Quinazolines; D000069347:Erlotinib Hydrochloride